International audienceSince the discovery of cisplatin, the search for diagnostic or therapeutic agents based on other metals, has expanded intensively owing to the numerous possibilities offered by coordination chemistry. This mini-review focuses on recent advances in the search for Ru(II) polyazaaromatic complexes of potential interest as molecular tools applied to cellular diagnostics or as specific cellular photo-reagents for future biomedical applications. The interaction of Ru(II) polyazaaromatic complexes with living cells is reported, as well as the photo-reaction mechanisms of photo-oxidizing Ru(II) complexes with nucleic acids. The novel strategies currently developed to improve their reactivity and specificity towards DNA, more p...
Ruthenium(II) [Ru(II)] polypyridyl complexes have been the focus of intense investigations since wor...
Ruthenium-polypyridyl complexes containing extended aromatic ring systems exhibit attractive photoph...
An important property of the Ru(II) complexes that contain polyazaaromatic ligands such as TAP (1,4,...
Since the discovery of cisplatin, the search for diagnostic or therapeutic agents based on other met...
Since the discovery of cisplatin, the search for therapeutic agents based on other metallic compound...
Since the discovery of the anticancer properties of cisplatin, using new metals has progressively ga...
Since the discovery of the anticancer properties of cisplatin, using new metals has progressively ga...
The design and characterization of new ruthenium(II) complexes aimed at targeting G-quadruplex DNA i...
RuII polyazaaromatic complexes have been studied with the aim of developing molecular tools for DNA ...
Ruthenium(II) polypyridyl complexes have been shown to be promising compounds for the design of nove...
Ruthenium(II) [Ru(II)] polypyridyl complexes have been the focus of intense investigations since wor...
International audienceThe design and characterization of new ruthenium(II) complexes aimed at target...
International audienceThe design and characterization of new ruthenium(II) complexes aimed at target...
This chapter describes the development of kinetically inert ruthenium(II) polypyridyl complexes (RPC...
Elaboration of new generations of more effective and safer metal-based anticancer agents, has been s...
Ruthenium(II) [Ru(II)] polypyridyl complexes have been the focus of intense investigations since wor...
Ruthenium-polypyridyl complexes containing extended aromatic ring systems exhibit attractive photoph...
An important property of the Ru(II) complexes that contain polyazaaromatic ligands such as TAP (1,4,...
Since the discovery of cisplatin, the search for diagnostic or therapeutic agents based on other met...
Since the discovery of cisplatin, the search for therapeutic agents based on other metallic compound...
Since the discovery of the anticancer properties of cisplatin, using new metals has progressively ga...
Since the discovery of the anticancer properties of cisplatin, using new metals has progressively ga...
The design and characterization of new ruthenium(II) complexes aimed at targeting G-quadruplex DNA i...
RuII polyazaaromatic complexes have been studied with the aim of developing molecular tools for DNA ...
Ruthenium(II) polypyridyl complexes have been shown to be promising compounds for the design of nove...
Ruthenium(II) [Ru(II)] polypyridyl complexes have been the focus of intense investigations since wor...
International audienceThe design and characterization of new ruthenium(II) complexes aimed at target...
International audienceThe design and characterization of new ruthenium(II) complexes aimed at target...
This chapter describes the development of kinetically inert ruthenium(II) polypyridyl complexes (RPC...
Elaboration of new generations of more effective and safer metal-based anticancer agents, has been s...
Ruthenium(II) [Ru(II)] polypyridyl complexes have been the focus of intense investigations since wor...
Ruthenium-polypyridyl complexes containing extended aromatic ring systems exhibit attractive photoph...
An important property of the Ru(II) complexes that contain polyazaaromatic ligands such as TAP (1,4,...